Structure Therapeutics Inc.(GPCR)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-24 | FMR LLC 10% Owner, Other | Sale | -52,356 | -2.89%1,759,886 | $16.69 | $873,822 | View SEC filing | |
| 2026-07-15 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale | -23,634 | -3.39%673,192 | $16.99 | $401,629 | View SEC filing | |
| 2026-04-16 | FMR LLC 10% Owner, Other | Sale | -52,356 | -2.81%1,812,242 | $18.36 | $961,082 | View SEC filing | |
| 2026-01-20 | FMR LLC 10% Owner, Other | Sale | -52,356 | -2.70%1,888,558 | $27.77 | $1,453,753 | View SEC filing | |
| 2025-12-10 | FMR LLC 10% Owner, Other | Sale | -157,068 | -7.27%2,002,301 | $23.99 | $3,768,430 | View SEC filing | |
| 2025-08-01 | FMR LLC 10% Owner, Other | Sale | -78,930 | -3.61%2,108,940 | $5.96 | $470,160 | View SEC filing | |
| 2025-02-10 | FMR LLC 10% Owner, Other | Sale | -123 | -0.01%2,135,250 | $10.18 | $1,252 | View SEC filing | |
| 2024-06-05 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale | -106,200 | -55.34%85,707 | $15.83 | $1,681,571 | View SEC filing | |
| 2024-03-18 | FMR LLC 10% Owner, Other | Sale | -65,991 | -2.97%2,152,745 | $11.67 | $769,895 | View SEC filing | |
| 2024-02-15 | FMR LLC 10% Owner, Other | Sale | -1,575 | -0.07%2,174,742 | $15.75 | $24,801 | View SEC filing | |
| 2023-12-07 | FMR LLC 10% Owner, Other | Sale | -52,362 | -33.34%104,706 | $20.82 | $1,090,177 | View SEC filing | |
| 2023-10-23 | FMR LLC 10% Owner, Other | Sale | -52,362 | -25.00%157,068 | $21.88 | $1,145,681 | View SEC filing | |
| 2023-02-09 | Farid Ramy Director | Purchase | +825,000 | +30.44%3,535,495 | $5.00 | $4,125,000 | View SEC filing | |
| 2023-02-09 | Jung Melita Sun Chief Business Officer | Purchase | +3,000 | +100.00%3,000 | $5.00 | $15,000 | View SEC filing | |
| 2023-02-09 | Bach Mark Allen Chief Medical Officer | Purchase | +4,500 | +100.00%4,500 | $5.00 | $22,500 | View SEC filing | |
| 2023-02-09 | Yoon Jun Chief Financial Officer | Purchase | +1,800 | +0.07%2,618,850 | $5.00 | $9,000 | View SEC filing | |
| 2023-02-09 | Stevens Raymond C Chief Executive Officer | Purchase | +12,000 | +0.46%2,622,250 | $5.00 | $60,000 | View SEC filing |
1-17 of 17